FluroTest Announces Pre-Emergency Use Authorization Filing with FDA; Provides Executive Update on Program Progress
12 juil. 2021 08h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, July 12, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...
FluroTech Announces Closing of Amalgamation
20 mai 2021 10h30 HE
|
FluroTech Ltd.
CALGARY, Alberta, May 20, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a diagnostics technology leader in high output rapid antigen testing for...
FluroTech Announces Extension to Early Warrant Exercise Incentive Program
07 mai 2021 08h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, May 07, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) ("FluroTech" or the "Company"), a leading developer of spectroscopy-based technology, is pleased to...
FluroTech Partners With Toolbox Medical Innovations for Clinical Trial of Mass-Scale COVID-19 Testing Platform
04 mars 2021 08h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, March 04, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with...
FluroTech and Hudson Robotics Begin Pandemic Response Unit Pre-Production
19 févr. 2021 08h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Feb. 19, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with...
Brian Shield, Boston Red Sox VP of IT, Joins Flurotech Advisory Board
04 févr. 2021 08h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Feb. 04, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with...
FluroTech Provides Executive Update on Program Advancements
03 févr. 2021 08h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Feb. 03, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with...
FluroTech Retains Market-Making Services
27 janv. 2021 16h10 HE
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 27, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that is has engaged Venture Liquidity Providers...
FluroTech Expands nanoComposix Mandate; Initiating Covid-19 Test Performance Evaluation and Validation
25 janv. 2021 09h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 25, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that, FluroTest Ltd. (“FluroTest”) has retained...
FluroTech Announces Closing of Oversubscribed $2.5 Million Private Placement Financing and Announces Communications Engagement for Investor Relations Services
21 janv. 2021 14h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Jan. 21, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that it has closed the second and final tranche...